In addition, Ge et al. and Xu et al. also reported that the anti-tumor effect of TSRP on HL-60 leukemia cells could inhibit the signaling pathways of STAT3, AMPK and eIF4E [19,20]. The gene discussed is STAT3; the disease is neoplasm.